Your browser doesn't support javascript.
loading
Efficacy, Safety, and Immunogenicity of an Escherichia coli-Produced Bivalent Human Papillomavirus Vaccine: An Interim Analysis of a Randomized Clinical Trial.
Qiao, You-Lin; Wu, Ting; Li, Rong-Cheng; Hu, Yue-Mei; Wei, Li-Hui; Li, Chang-Gui; Chen, Wen; Huang, Shou-Jie; Zhao, Fang-Hui; Li, Ming-Qiang; Pan, Qin-Jing; Zhang, Xun; Li, Qing; Hong, Ying; Zhao, Chao; Zhang, Wen-Hua; Li, Yan-Ping; Chu, Kai; Li, Mei; Jiang, Yun-Fei; Li, Juan; Zhao, Hui; Lin, Zhi-Jie; Cui, Xue-Lian; Liu, Wen-Yu; Li, Cai-Hong; Guo, Dong-Ping; Ke, Li-Dong; Wu, Xin; Tang, Jie; Gao, Guo-Qi; Li, Ba-Yi; Zhao, Bin; Zheng, Feng-Xian; Dai, Cui-Hong; Guo, Meng; Zhao, Jun; Su, Ying-Ying; Wang, Jun-Zhi; Zhu, Feng-Cai; Li, Shao-Wei; Pan, Hui-Rong; Li, Yi-Min; Zhang, Jun; Xia, Ning-Shao.
Afiliação
  • Qiao YL; National Cancer Center, National Center for Cancer Clinical Research, The Cancer Institute, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, China.
  • Wu T; The State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Collaborative Innovation Center of Biologic Products, School of Public Health, Xiamen University, Xiamen, Fujian, China.
  • Li RC; Guangxi Center for Disease Control and Prevention, Nanning, Guangxi, China.
  • Hu YM; Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, Jiangsu, China.
  • Wei LH; Peking University People's Hospital, Beijing, China.
  • Li CG; National Institute for Food and Drug Control, Beijing, China.
  • Chen W; National Cancer Center, National Center for Cancer Clinical Research, The Cancer Institute, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, China.
  • Huang SJ; The State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Collaborative Innovation Center of Biologic Products, School of Public Health, Xiamen University, Xiamen, Fujian, China.
  • Zhao FH; National Cancer Center, National Center for Cancer Clinical Research, The Cancer Institute, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, China.
  • Li MQ; Liuzhou Center for Disease Control and Prevention, Liuzhou, Guangxi, China.
  • Pan QJ; National Cancer Center, National Center for Cancer Clinical Research, The Cancer Institute, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, China.
  • Zhang X; National Cancer Center, National Center for Cancer Clinical Research, The Cancer Institute, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, China.
  • Li Q; Xinmi Maternal and Child Health Hospital, Xinmi, Henan, China.
  • Hong Y; Shenzhen Maternity and Child Healthcare Hospital, Shenzhen, Guangdong, China.
  • Zhao C; The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China.
  • Zhang WH; Peking University People's Hospital, Beijing, China.
  • Li YP; National Cancer Center, National Center for Cancer Clinical Research, The Cancer Institute, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, China.
  • Chu K; Guangxi Center for Disease Control and Prevention, Nanning, Guangxi, China.
  • Li M; Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, Jiangsu, China.
  • Jiang YF; The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China.
  • Li J; The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China.
  • Zhao H; National Institute for Food and Drug Control, Beijing, China.
  • Lin ZJ; National Institute for Food and Drug Control, Beijing, China.
  • Cui XL; Xiamen Innovax Biotech Company, Xiamen, Fujian, China.
  • Liu WY; Liuzhou Center for Disease Control and Prevention, Liuzhou, Guangxi, China.
  • Li CH; Funing Center for Disease Control and Prevention, Funing, Jiangsu, China.
  • Guo DP; Xinmi Maternal and Child Health Hospital, Xinmi, Henan, China.
  • Ke LD; Yangcheng Maternal and Child Health Hospital, Yangcheng, Shanxi, China.
  • Wu X; Fengning Hospital of Traditional Chinese Medicine, Fengning, Hebei, China.
  • Tang J; Liuzhou Center for Disease Control and Prevention, Liuzhou, Guangxi, China.
  • Gao GQ; Funing Center for Disease Control and Prevention, Funing, Jiangsu, China.
  • Li BY; Xinmi Maternal and Child Health Hospital, Xinmi, Henan, China.
  • Zhao B; Yangcheng Maternal and Child Health Hospital, Yangcheng, Shanxi, China.
  • Zheng FX; Fengning Hospital of Traditional Chinese Medicine, Fengning, Hebei, China.
  • Dai CH; Xinmi Maternal and Child Health Hospital, Xinmi, Henan, China.
  • Guo M; Fengning Hospital of Traditional Chinese Medicine, Fengning, Hebei, China.
  • Zhao J; The State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Collaborative Innovation Center of Biologic Products, School of Public Health, Xiamen University, Xiamen, Fujian, China.
  • Su YY; The State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Collaborative Innovation Center of Biologic Products, School of Public Health, Xiamen University, Xiamen, Fujian, China.
  • Wang JZ; The State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Collaborative Innovation Center of Biologic Products, School of Public Health, Xiamen University, Xiamen, Fujian, China.
  • Zhu FC; National Institute for Food and Drug Control, Beijing, China.
  • Li SW; Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, Jiangsu, China.
  • Pan HR; The State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Collaborative Innovation Center of Biologic Products, School of Public Health, Xiamen University, Xiamen, Fujian, China.
  • Li YM; Xiamen Innovax Biotech Company, Xiamen, Fujian, China.
  • Zhang J; Xiamen Innovax Biotech Company, Xiamen, Fujian, China.
  • Xia NS; The State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Collaborative Innovation Center of Biologic Products, School of Public Health, Xiamen University, Xiamen, Fujian, China.
J Natl Cancer Inst ; 112(2): 145-153, 2020 02 01.
Article em En | MEDLINE | ID: mdl-31086947
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Papillomaviridae / Infecções por Papillomavirus / Vacinas contra Papillomavirus / Imunogenicidade da Vacina Tipo de estudo: Clinical_trials / Etiology_studies / Guideline Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Natl Cancer Inst Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Papillomaviridae / Infecções por Papillomavirus / Vacinas contra Papillomavirus / Imunogenicidade da Vacina Tipo de estudo: Clinical_trials / Etiology_studies / Guideline Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Natl Cancer Inst Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China